- Home
- ZEUS vs FDMT Comparison
ZEUS vs FDMT Comparison
Compare ZEUS & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZEUS | FDMT |
|---|---|---|
| Founded | 1954 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 551.5M | 466.7M |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ZEUS | FDMT |
|---|---|---|
| Price | $51.14 | $8.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $38.00 | $34.13 |
| AVG Volume (30 Days) | 96.8K | ★ 793.8K |
| Earning Date | 02-19-2026 | 02-27-2026 |
| Dividend Yield | ★ 1.26% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.17 | N/A |
| Revenue | ★ $1,898,863,000.00 | $120,000.00 |
| Revenue This Year | $0.48 | $21,227.03 |
| Revenue Next Year | $2.77 | $161.87 |
| P/E Ratio | $43.35 | ★ N/A |
| Revenue Growth | N/A | ★ 605.88 |
| 52 Week Low | $26.32 | $2.24 |
| 52 Week High | $52.65 | $12.34 |
Technical Indicators
Market Signals| Indicator | ZEUS | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 62.84 | 49.83 |
| Support Level | $50.45 | $8.39 |
| Resistance Level | $52.65 | $9.78 |
| Average True Range (ATR) | 1.60 | 0.58 |
| MACD | -0.02 | 0.12 |
| Stochastic Oscillator | 78.36 | 49.90 |
Price Performance
Historical ComparisonAbout ZEUS Olympic Steel Inc.
Olympic Steel Inc provides metals processing and distribution services in the United States. The company operates in three reportable segments; specialty metals flat products, carbon flat products, and tubular and pipe products. It specializes in the processing and distribution of large volumes of carbon, aluminum, and stainless steel flat-rolled sheet, coils, plates, bars, and fabricated parts. The group serves various industries such as industrial machinery and equipment manufacturers, automobile manufacturers and suppliers, and transportation equipment manufacturers. The company generates majority of the revenue from carbon flat products.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.